- In April 2023, Glooko, Inc., a leading software company, entered into a global partnership with Hedia, a developer of insulin dosing algorithms. This collaboration aims to create an interoperable solution that combines remote patient monitoring, connected care, and digital therapeutic technologies. By doing so, they seek to enhance access for individuals with Type 1 and Type 2 diabetes who require guidance on bolus insulin dosing
- In May 2023, Medtronic plc, a leading global healthcare technology company, announced definitive agreements to acquire EOFlow Co. Ltd., known for its innovative wearable insulin patches. This acquisition aims to enhance automated insulin delivery capabilities and streamline diabetes treatment for patients. By incorporating EOFlow's technology, Medtronic seeks to bolster its position in the industry while expanding its product offerings to better serve individuals managing diabetes
- In October 2021, Roche partnered with the Zur Rose Group to enhance support for individuals with diabetes and their caregivers in managing daily medications. This collaboration aims to integrate Roche Diabetes Care’s solutions with those of leading third-party providers, creating a more comprehensive healthcare ecosystem. By connecting their innovative healthcare products, Roche and Zur Rose Group seek to improve the overall quality of life for people living with diabetes
